Nobuharu Fujii

Medicine & Life Sciences

1. Hematopoietic Stem Cell Transplantation 100%
2. Cell Transplantation 60%
3. Peripheral Blood Stem Cell Transplantation 58%
4. Graft vs Host Disease 54%
5. Drug Therapy 40%
6. Lymphoma 38%
7. Japan 37%
8. Transplants 37%
9. Allogeneic Cells 34%
10. Tissue Donors 33%
11. Transplantation 33%
12. Fertility Preservation 33%
13. Leukemia 32%
14. Myelodysplastic Syndromes 30%
15. Fetal Blood 29%
16. Minor Histocompatibility Antigens 26%
17. Medical Oncology 24%
18. T-Lymphocytes 24%
19. Therapeutics 20%
20. Bone Marrow 20%
21. Neoplasms 20%
22. Hematologic Neoplasms 19%
23. Lung 18%
24. Cell Line 17%
25. Young Adult 17%
26. HLA Antigens 17%
27. Cyclophosphamide 17%
28. Peripheral Blood Stem Cells 17%
29. Adult T Cell Leukemia Lymphoma 16%
30. Epstein-Barr Virus Infections 16%
31. Granulocyte Colony-Stimulating Factor 16%
32. Rituximab 16%
33. axicabtagene ciloleucel 15%
34. Blood Cells 15%
35. B-Cell Lymphoma 15%
36. Multicenter Studies 14%
37. Neutrophils 14%
38. Stem Cell Transplantation 14%
39. Bone Marrow Transplantation 14%
40. Bronchiolitis Obliterans 14%
41. Follicular Lymphoma 13%
42. Lymphocytes 13%
43. Cryptogenic Organizing Pneumonia 13%
44. Non-Hodgkin's Lymphoma 13%
45. Hematopoietic Stem Cells 13%
46. Haploidentical Transplantation 13%
47. Trisomy Chromosome 8 13%
48. Acute Myeloid Leukemia 13%
49. Stem Cells 13%
50. INCB018424 12%